David Bouchey
Stock Analyst at Aegis Capital
(0)
# 5298
Out of 5,333 analysts
7
Total ratings
0.00%
Success rate
-77.22%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SBFM Sunshine Biopharma | Reiterates: Buy | 15 15 | 1.24 | 1109.68% | 2 | Dec 5, 2024 | |
STSS Sharps Technology | Initiates Coverage On: Buy | 105600 | n/a | n/a | 1 | May 9, 2023 | |
ATXI Avenue Therapeutics | Initiates Coverage On: Buy | 2400 | 0.24 | 999900% | 1 | Apr 3, 2023 | |
IINN Inspira Technologies Oxy | Maintains: Buy | 10 13 | 0.56 | 2221.43% | 1 | Jan 25, 2023 | |
RMTI Rockwell Medical | Downgrades: Outperform | 121 | 1.11 | 10800.9% | 2 | Oct 19, 2018 |